CYP17A1-AS1 Gene

Name CYP17A1 antisense RNA 1
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Variants at the 10q24.32 locus have been shown to influence the expression of several genes, including the antisense RNA gene CYP17A1‐AS1. In one study examining arsenic metabolism efficiency, the causal SNP rs4919690 was associated with decreased expression of AS3MT and, in a tissue‐specific manner, of CYP17A1‐AS1 among other nearby genes (e.g., BORCS7, NT5C2, and RP11‐724N1.1)."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " Although CYP17A1‐AS1 expression was detected in only one tissue type in this context, its coordinated regulation with genes known to modulate arsenic biotransformation suggests that it may play a role—directly or indirectly—in the metabolic handling of environmental toxins.\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Moreover, integrative genomic analyses that combine genome‐wide association study data with expression quantitative trait loci (eQTL) information have linked noncoding and intergenic regions of 10q24.32 with a range of disease comorbidities and clinical syndromes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " Similarly, investigations into the genetic architecture of neuropsychiatric conditions, such as schizophrenia, underscore the importance of this genomic region in disease risk."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Thus, while the precise mechanistic function of CYP17A1‐AS1 remains to be fully elucidated, current evidence indicates that its expression is modulated by genetic variation at 10q24.32. This modulation may contribute to alterations in arsenic metabolism and potentially influence broader molecular pathways implicated in comorbid and neuropsychiatric diseases.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Meytal Chernoff, Lin Tong, Kathryn Demanelis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic Determinants of Reduced Arsenic Metabolism Efficiency in the 10q24.32 Region Are Associated With Reduced AS3MT Expression in Multiple Human Tissue Types."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Toxicol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/toxsci/kfaa075"}], "href": "https://doi.org/10.1093/toxsci/kfaa075"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32433756"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32433756"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Haiquan Li, Jungwei Fan, Francesca Vitali, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel disease syndromes unveiled by integrative multiscale network analysis of diseases sharing molecular effectors and comorbidities."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Med Genomics (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12920-018-0428-9"}], "href": "https://doi.org/10.1186/s12920-018-0428-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30598089"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30598089"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Zhi-Hui Yang, Xin Cai, Na Qu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of a functional 339 bp "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "Alu"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " insertion polymorphism in the schizophrenia-associated locus at 10q24.32."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zool Res (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.24272/j.issn.2095-8137.2020.014"}], "href": "https://doi.org/10.24272/j.issn.2095-8137.2020.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31840948"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31840948"}]}]}]}
Synonyms CYP17A1OS, BA753C18.3
NCBI Gene ID 102724307
API
Download Associations
Predicted Functions View CYP17A1-AS1's ARCHS4 Predicted Functions.
Co-expressed Genes View CYP17A1-AS1's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View CYP17A1-AS1's ARCHS4 Predicted Functions.

Functional Associations

CYP17A1-AS1 has 589 functional associations with biological entities spanning 2 categories (disease, phenotype or trait, cell line, cell type or tissue) extracted from 5 datasets.

Click the + buttons to view associations for CYP17A1-AS1 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
GTEx Tissue Gene Expression Profiles tissues with high or low expression of CYP17A1-AS1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of CYP17A1-AS1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GWASdb SNP-Disease Associations diseases associated with CYP17A1-AS1 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.
GWASdb SNP-Phenotype Associations phenotypes associated with CYP17A1-AS1 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of CYP17A1-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.